Telix Pharmaceuticals (TLX) Debt Ratio (2023 - 2025)

Telix Pharmaceuticals (TLX) has 3 years of Debt Ratio data on file, last reported at 0.35 in Q4 2025.

• Debt Ratio for Q4 2025 came in at 0.35, down 7.56% year-over-year; the trailing twelve-month figure through Dec 2024 was 0.38 (up 1565.86% YoY), and the FY2025 annual result was 0.35, down 7.56% from the prior year.
• Debt Ratio eased to 0.35 in Q4 2025 per TLX's latest filing, from 0.38 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.38 in Q4 2024 and troughed at 0.02 in Q4 2023.
• A 3-year average of 0.25 and a median of 0.35 in 2025 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2024 and 2025: Debt Ratio jumped 1565.86% in 2024, then declined 7.56% in 2025.
• A 3-year view of Debt Ratio shows it stood at 0.02 in 2023, then surged by 1565.86% to 0.38 in 2024, then dropped by 7.56% to 0.35 in 2025.
• Business Quant data shows TLX's Debt Ratio at 0.35 in Q4 2025, 0.38 in Q4 2024, and 0.02 in Q4 2023.